Abstract
Approximately one decade, carbon nanoparticles have been contemplated as a new proposal for the treatment of various pathological conditions, including cancer. This potential is based mainly on the capability of these nanoparticles to cross the membrane of live cells, and thus can act as an important carrier for drugs to the tumor site while reducing their side effects. Carbon nanotubes m…